GlassScriptPhysician profile
Jihad Tahsin Abbas
NPI 1245234129
$5,445.77
in general payments reported to CMS, 2019-2025
37 companies · $1,041 in 2025
The $1,041 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $723 · 2020: $296 · 2021: $495 · 2022: $861 · 2023: $1,008 · 2024: $1,023 · 2025: $1,041.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,964 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,963.83 |
| Education | $107.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $1,257.06 | 2022-2025 | Torus Stent Graft System, Endocross Device, Alto Abdominal Stent Graft System |
| Medtronic, INC. | $500.17 | 2021-2025 | Endurant Iis, Valiant Captivia, Heli-Fx Endoanchor System |
| Bard Peripheral Vascular, INC. | $468.54 | 2019-2025 | Wavelinq, Lutonix Drug Coated Balloon |
| Penumbra, INC. | $431.79 | 2020-2024 | Indigo System |
| Integra Lifesciences Corporation | $266.50 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Boston Scientific Corporation | $224.94 | 2019-2025 | General - Atherectomy |
| Cook Medical LLC | $217.53 | 2019-2025 | Zilver Ptx, Zenith, Lunderquist |
| Janssen Pharmaceuticals, INC | $184.30 | 2019-2024 | Xarelto |
| Smith+Nephew, INC. | $181.27 | 2019-2025 | Grafix Pl |
| Silk Road Medical, INC. | $162.82 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Janssen Scientific Affairs, LLC | $154.37 | 2021-2022 | |
| Becton, Dickinson and Company | $135.34 | 2019 | |
| Pfizer INC. | $133.27 | 2022-2025 | |
| Lemaitre Vascular, INC. | $119.76 | 2023-2025 | Restoreflow, Xenosure Biologic Patch, Artegraft Vascular Graft |
| Medline Industries LP | $106.66 | 2019 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $105.95 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $96.54 | 2024-2025 | |
| Medtronic Vascular, INC. | $94.51 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $81.53 | 2019-2022 | |
| Inari Medical, INC. | $78.04 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kerecis Limited | $75.93 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Tactile Systems Technology INC | $45.22 | 2020 | |
| Organogenesis INC. | $44.46 | 2024-2025 | Puraply Wound Matrix |
| Bsn Medical INC | $39.74 | 2022 | |
| Allergan, INC. | $38.25 | 2020 | |
| Nevro Corp. | $27.32 | 2024 | Senza |
| Stryker Corporation | $26.55 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Aroa Biosurgery Incorporated | $22.95 | 2024 | |
| My01 INC. | $21.75 | 2023 | My01 Continuous Compartmental Pressure Monitor |
| Lifenet Health | $21.56 | 2024 | Theragenesis Wound Matrix |
| Cardiovascular Systems INC. | $18.40 | 2023 | |
| Chiesi USA, INC. | $15.45 | 2025 | Cleviprex |
| Thrombolex, INC. | $12.07 | 2025 | Bashir Endovascular Catheter |
| W. L. Gore & Associates, INC. | $11.80 | 2019 | |
| Venturemed Group, INC. | $11.72 | 2019 | |
| Ethicon US, LLC | $11.71 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jihad Abbas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.